MENU
+Compare
YMAB
Stock ticker: NASDAQ
AS OF
May 22, 04:59 PM (EDT)
Price
$4.12
Change
+$0.02 (+0.49%)
Capitalization
187.02M

YMAB Y-mAbs Therapeutics Forecast, Technical & Fundamental Analysis

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company... Show more

YMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for YMAB with price predictions
May 21, 2025

Momentum Indicator for YMAB turns positive, indicating new upward trend

YMAB saw its Momentum Indicator move above the 0 level on May 20, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where YMAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for YMAB just turned positive on May 16, 2025. Looking at past instances where YMAB's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where YMAB advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

YMAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

YMAB moved below its 50-day moving average on April 16, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where YMAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for YMAB entered a downward trend on May 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.091) is normal, around the industry mean (16.392). P/E Ratio (0.000) is within average values for comparable stocks, (59.359). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.199). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (2.080) is also within normal values, averaging (279.777).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. YMAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YMAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
YMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

YMAB is expected to report earnings to rise 107.42% to -24 cents per share on August 07

Y-mAbs Therapeutics YMAB Stock Earnings Reports
Q2'25
Est.
$-0.25
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.03
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.09
The last earnings report on May 13 showed earnings per share of -11 cents, beating the estimate of -19 cents. With 94.64K shares outstanding, the current market capitalization sits at 187.02M.
A.I. Advisor
published General Information

General Information

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME30.862.81
+10.02%
GameStop Corp
TSLA341.046.42
+1.92%
Tesla
BTC.X111673.2800001995.203100
+1.82%
Bitcoin cryptocurrency
SPY583.090.23
+0.04%
SPDR® S&P 500® ETF
AAPL201.36-0.73
-0.36%
Apple

YMAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, YMAB has been loosely correlated with ARWR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if YMAB jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YMAB
1D Price
Change %
YMAB100%
-3.07%
ARWR - YMAB
52%
Loosely correlated
-6.02%
RCKT - YMAB
50%
Loosely correlated
-3.80%
CRSP - YMAB
50%
Loosely correlated
-5.76%
NTLA - YMAB
48%
Loosely correlated
-4.86%
IMNM - YMAB
47%
Loosely correlated
-7.48%
More